Cortisol, aldosterone, cortisol precursor, androgen and endogenous ACTH concentrations in dogs with pituitary-dependant hyperadrenocorticism treated with trilostane

Domestic Animal Endocrinology

Volumn 31, Issue 1, 2006, Pages 63-75

  Sieber Ruckstuhl, N S ^a   Boretti, F S ^a   Wenger, M ^a   Maser Gluth, C ^b   Reusch, C E ^a  

^a VETSUISSE FACULTY UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Dogs; Endogenous ACTH; Hyperadrenocorticism; Steroid hormone concentrations; Trilostane

Indexed keywords

17 HYDROXYPREGNENOLONE; 21 DEOXYHYDROCORTISONE; 21-DEOXYCORTISOL; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; ANDROSTANOLONE; ANDROSTENEDIONE; CORTICOTROPIN; CORTODOXONE; DRUG DERIVATIVE; ENZYME INHIBITOR; HYDROCORTISONE; PRASTERONE; TRILOSTANE;

ADRENAL CORTEX HYPERFUNCTION; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; DOG; DOG DISEASE; DRUG ANTAGONISM; FEMALE; MALE; NONPARAMETRIC TEST; PROSPECTIVE STUDY;

17-ALPHA-HYDROXYPREGNENOLONE; 3-HYDROXYSTEROID DEHYDROGENASES; ADRENOCORTICAL HYPERFUNCTION; ADRENOCORTICOTROPIC HORMONE; ALDOSTERONE; ANDROSTENEDIONE; ANIMALS; CORTODOXONE; DEHYDROEPIANDROSTERONE; DIHYDROTESTOSTERONE; DOG DISEASES; DOGS; ENZYME INHIBITORS; FEMALE; HYDROCORTISONE; MALE; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

CANIS FAMILIARIS;

EID: 33646825678     PISSN: 07397240     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.domaniend.2005.09.004     Document Type: Article

References (24)

1. Neumann H.C., Potts G.O., Ryan W.T., and Stonner F.W. Steroidal heterocycles. XIII. 4α,5-Epoxy-5α-androst-2-eno[2,3-d]isoxazoles and related compounds. J Med Chem 13 5 (1970) 948-951
2. Potts G.O., Creange J.E., Harding H.R., and Schane H.P. Trilostane, an orally active inhibitor of steroid biosynthesis. Steroids 32 2 (1978) 257-267
3. Schane H.P., Potts G.O., and Creange J.E. Inhibition of ovarian, placental, and adrenal steroidogenesis in the rhesus monkey by trilostane. Fert Steril 32 4 (1979) 464-467
4. Lambert F., Corcelle-Cerf F., Lammerant J., and Kolanowski J. On the specificity of the inhibitory effect of trilostane and aminoglutethimide on adrenocortical steroidogenesis in guinea pig. Mol Cell Endocrinol 37 (1984) 115-120
5. Komanicky P., Spark R.F., and Melby J.C. Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis. J Clin Endocrinol Metab 47 (1978) 1042-1051
6. Semple C.G., Beastall G.H., Gray C.E., and Thomson J.A. Trilostane in the management of Cushing's syndrome. Acta Endocrinol 102 (1983) 107-110
7. Nomura K., Demura H., Imaki T., Miyagawa M., Ono M., Yano T., and Shizume K. Concomitant falls of plasma cortisol and ACTH levels in a case of Cushing's disease during treatment with trilostane. Acta Endocrinol 105 (1984) 93-98
8. Nakada T., Kazama T., Koike H., Yoshikawa M., Ishikawa S., and Katayama T. Primary aldosteronism treated by trilostane (3β-hydroxysteroid dehydrogenase inhibitor). Urology 25 2 (1985) 207-214
9. Nomura K., Demura H., Horiba N., and Shizume K. Long-term treatment of idiopathic hyperaldosteronism using trilostane. Acta Endocrinol 113 (1986) 104-110
10. Vierhapper H., Nowotny P., and Waldhäusl W. Effect of trilostane on steroid excretion in man: compensated inhibition of 3β-hydroxysteroid dehydrogenase. J Steroid Biochem 24 2 (1986) 577-580
11. Ruckstuhl N.S., Nett C.S., and Reusch C.E. Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependant hyperadrenocorticism treated with trilostane. Am J Vet Res 63 4 (2002) 506-512
12. Neiger R., Ramsey I., O'Connor J., Hurley K.J., and Mooney C.T. Trilostane treatment of 78 dogs with pituitary-dependant hyperadrenocorticism. Vet Rec 150 (2002) 799-804
13. Wenger M., Sieber-Ruckstuhl N.S., Müller C., and Reusch C.E. Effect of trilostane on serum concentrations of aldosterone, cortisol, and potassium in dogs with pituitary-dependent hyperadrenocorticism. Am J Vet Res 65 9 (2004) 1245-1250
14. Ristic J.M.E., Ramsey I.K., Heath F.M., Evans H.J., and Herrtage M.E. The use of 17-hydroxyprogesterone in the diagnosis of canine hyperadrenocorticism. J Vet Intern Med 16 (2002) 433-439
15. Cerundolo R., Lloyd D.H., Persechino A., Evans H., and Cauvin A. Treatment of canine alopecia X with trilostane. Vet Dermatol 15 (2004) 285-293
16. Bosje T.J., Rijnberk A., Mol J.A., Voorhout G., and Kooistra H.S. Plasma concentrations of ACTH precursors correlate with pituitary size and resistance to dexamethasone in dogs with pituitary-dependant hyperadrenocorticism. Dom Anim Endocrinol 22 (2002) 201-210
17. Vecsei P., Akanbou C., Joumaah A., and Sallum N.I. Studies on antibodies against corticoid hormones. Acta Endocrinol (Kbh) 69 Suppl. 159 (1972) 33-45
18. Vecsei P. Radioimmunoassay. Med Klin 73 (1978) 497-507
19. Vecsei P. Glucocorticoids: cortisol, cortisone, corticosterone, compound S, and their metabolites. In: Jaffe B.M., and Behrmann H.R. (Eds). Methods of hormone radioimmunoassays (1979), Academic Press, New York 767-796
20. Abraham G.E., Buster J.E., Lucas L.A., Corrales P.C., and Teller R.C. Chromatographic separation of steroid hormones for use in radioimmunoassays. Anal Lett 5 (1972) 509-517
21. Witt A.L., and Neiger R. Adrencorticotropic hormone levels in dogs with pituitary-dependent hyperadrenocorticism following trilostane therapy. Vet Rec 154 (2004) 399-400
22. Touitou Y., Auzeby A., Bogdan A., Luton J.P., and Galan P. 11β-Hydroxy-11-ketosteroids equilibrium, a source of misinterpretation in steroid synthesis: evidence through the effects of trilostane on 11β-hydroxysteroid dehydrogenase in sheep and human adrenals in vitro. J Steroid Biochem 20 3 (1984) 763-768
23. Krozowski Z., Li K.X.Z., Koyama K., Smith R.E., Obeyesekere V.R., Stein-Oakley A., Sasano H., Coulter C., Cole T., and Sheppard K.E. The type I and type II 11β-hydroxysteroid dehydrogenase enzymes. J Steroid Biochem Met 69 (1999) 391-401
24. Andrew R. Clinical measurement of steroid metabolism. Best Pract Res Clin Endocrinol Metab 15 1 (2001) 1-16